This insight brief summarizes discussions from a roundtable of midsize pharmaceutical leaders focused on navigating growth, portfolio focus, and organizational transformation. Key themes include balancing innovation with operational efficiency, scaling capabilities without losing agility, and leveraging data and partnerships to compete with larger players. Participants highlighted challenges in commercialization, talent, and capital allocation, alongside opportunities created by specialty therapies and targeted indications. IQVIA emphasizes that clear strategic focus, disciplined execution, and integrated evidence and analytics are critical for midsize pharma success.

Join for free to read